Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 21, 345-352, April 1, 1961]
© 1961 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hampton, E. G.
Right arrow Articles by Eidinoff, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hampton, E. G.
Right arrow Articles by Eidinoff, M. L.

Administration of 5-Iododeoxyuridine-I131 in the Mouse and Rat*

E. Gambetta Hampton and Maxwell L. Eidinoff

( Division of Biophysics, Sloan-Kettering Institute for Cancer Research, Sloan-Kettering Division of Cornell, University Medical College, New York, N.Y.)

5-Iododeoxyuridine-I131 was administered to normal as well as tumor-bearing rats and mice, and the effect of several variables on the disposition of the administered compound and on the I131 content of selected tissues was studied. Incorporation of the iodouracil moiety into the DNA of tumor and intestine was demonstrated.

Simultaneous administration of a large excess of 5-iodouridine, together with the 5-iododeoxyuridine-I131, did not significantly affect the I131 content of tumor and intestine. Administration of the labeled compound intraperitoneally as an oil emulsion rather than as an aqueous solution appreciably increased the incorporation of the iodouracil moiety into the DNA of tumor tissue. Administration of 5-iododeoxyuridine-5'-phosphate did not appreciably alter the incorporation of the iodouracil moiety as compared with an equimolar dose of 5-iododeoxyuridine.

* Supported by research grants from the National Institutes of Health (C3811) and the U.S. Atomic Energy Commission (AT-(30-1)-910).

Received 9/ 6/60.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1961 by the American Association for Cancer Research.